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Objectives: The internet is a valuable resource for accessing health information 
and support. This study aimed to develop a tool (the eHIQ) to measure the impact 
of using health-related websites which contain experiential and factual informa-
tion. MethOds: A multi-method study with four stages. Stage 1: Themes concern-
ing the impact of using health-related websites were identified through qualitative 
secondary analysis of interviews exploring patient and carer experiences of health 
and a relevant literature review. Stage 2: Questionnaire items based upon identified 
themes were constructed and assessed using expert and patient opinion. Stage 
3: Items were administered online and subjected to exploratory factor analysis. 
Stage 4: The reduced questionnaire and appropriate reference measures were 
administered online to test convergent validity and external reliability. Results: 
Sixty-seven items were constructed according to the key themes identified through 
relevant literature and qualitative analysis. Following expert and patient refinement, 
two independent item pools were entered into psychometric testing. The first item 
pool (eHIQ-Part 1) related to general views of using the internet in relation to health 
and second item pool (eHIQ-Part2) related to the impact of using a specific health-
related website. Analysis confirmed three domains present in eHIQ-Part 1 and six 
domains present in eHIQ-Part 2. These domains were tested further during Stage 4 
and were found to have high convergent validity, internal consistency and good test-
retest reliability. cOnclusiOns: Developing the eHIQ through the use of qualitative 
analysis and patient-expert opinion enhanced face and content validity. The eHIQ 
demonstrates good psychometric properties and will enable the measurement of 
the effects of using health-related websites across a range conditions.
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Objectives: Physicians treating systemic lupus erythematosus (SLE) use a variety 
of tools to monitor disease activity and organ damage however these do not capture 
the functional burden experienced by patients. Studies suggest that communication 
between physicians and patients need to be optimized. The Lupus Impact Tracker 
(LIT), a brief, disease specific 10-item patient reported outcome tool, was developed 
to assess the impact of SLE on patients daily functioning and well-being. This study 
aims to evaluate the cross-cultural validity, acceptability and feasibility of the LIT in 
European clinical practice settings. Potential effect of LIT on communication during 
the consultation will also be assessed. MethOds: This is a prospective, observa-
tional, multicenter cross-sectional validation study of SLE patients on standard of 
care from hospital/clinical settings in five European countries (France, Germany, 
Italy, Spain and Sweden). 625 patients enrolled to obtain at least 500 evaluable cases 
irrespective of disease severity. Before the visit, patients will complete self-reported 
questionnaires: SF-36, Global Evaluation of Change (GEC), care satisfaction and LIT. 
During visits, physicians will record patient data, assess disease activity using the 
SELENA-SLEDAI and Physician Global Assessment (PGA), and disease damage using 
the SLICC/ACR damage index. After the visit patients and physicians complete LIT 
feedback questionnaires. Analyses will be performed using descriptive statistical 
methods with no specific hypothesis suggested. Results: Psychometric evalua-
tion of LIT in US clinical settings found the tool reliable and valid. Evaluation for 
use in European clinical practice settings is thus needed. Cross-cultural validity 
of LIT across countries will be analyzed using differential item functioning (DIF) 
analysis. Data from the Lupus Impact Tracker-(Patient and Physician) Feedback 
Questionnaires will be tabulated and summarized. cOnclusiOns: We need 
improvement of the patient/physician interaction in lupus care. The LIT may be 
a valid and acceptable tool for use with SLE patients in European clinical practice 
settings.
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Objectives: To screen food-related products and support allegation demands, evalu-
ating food-related concepts with appropriate tools is essential. In the absence of such 
a tool, we developed a specific questionnaire providing insight into the way a person 
links food to well-being in terms of pleasure, joint comfort, digestive comfort, pre-
vention and immunity. MethOds: Semi-directive interviews were conducted with 
40 healthy subjects to explore three themes: food, well-being and food-related well-
being, and determine the basis of the interview guide for focus group discussions. 
Twenty-four group discussions (199 subjects in total) were conducted with healthy 
subjects (n= 12) and subjects with joint, digestive or repetitive infection complaints 
(n= 4 per complaint), to investigate definition and experience of food-related well-
being. Qualitative analysis was performed to identify concepts of interest. Based on 
the designed conceptual model and discussion with the scientific committee, items 
were generated using subjects’ verbatim expression. Face-to-face cognitive interviews 
were conducted with 29 healthy subjects to ensure comprehension and appropri-
Objectives: This research explored the feasibility of using mobile technology 
(mHealth) to capture data such as resource utilisation and patient reported 
outcomes to support the market access of new products. The main objectives 
were to understand best practices in engaging end users to optimise data col-
lection, and to explore payer opinions on the validity of using mHealth for 
data collection and its usefulness in the decision making process. MethOds: 
Secondary research was conducted to identify best practices in optimising 
end user engagement with mHealth solutions. Studies that led to success-
ful outcomes were analysed in detail to understand the key engagement suc-
cess factors. Qualitative primary payer interviews were conducted in several 
key European markets to understand the validity of using mHealth to collect 
data including perceived challenges of leveraging this data to support market 
access decisions. Results: Research showed that interventions that are person-
alised through data, analytics and behaviour change methodologies are most 
successful in engaging end users when using mHealth. Payers highlighted sev-
eral key concerns of using mHealth; namely, data quality and sustainability/ 
scalability. These concerns should be considered and addressed by health care 
companies who wish to use mHealth as a data platform to support payer deci-
sions. cOnclusiOns: mHealth is a tool that holds promise for many different 
parts of the health care value chain. This includes leveraging mHealth to support 
the market access targets of new products, by collecting and using data to enhance 
the communication of the products’ value. The findings from this research high-
light best practices to engage users in order to optimise data collection as well as 
provide insights from payers on the key concerns of doing so.
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Objectives: In 2010, the National Institute for Health and Clinical Excellence 
(NICE) performed a multiple technology assessment for second line biologic 
treatments (following the failure of a TNF inhibitor and disease modifying anti-
rheumatic drugs (DMARDs)) for the treatment of rheumatoid arthritis (RA). The 
Birmingham RA Model (BRAM) was used to obtain incremental cost-effectiveness 
ratios (ICERs) of £21,100/quality-adjusted life year (QALY) for rituximab versus 
DMARDs and £130,600 for abatacept versus rituximab. Adalimumab, etanercept 
and infliximab were dominated by rituximab. NICE recommended rituximab, 
unless contraindicated, in which case all the other biologics were recommended. 
The BRAM used in the NICE assessment used a linear regression model to trans-
late Health Assessment Questionnaire (HAQ) scores into EQ-5D scores, however 
other algorithms exist. The objective of this study was to understand how the 
algorithm used to map from HAQ to EQ-5D affects the ICERs generated by the 
model. MethOds: The BRAM used in the NICE assessment used a linear regres-
sion model to translate Health Assessment Questionnaire (HAQ) scores into EQ-5D 
scores, however other algorithms exist. The objective of this study was to under-
stand how the algorithm used to map from HAQ to EQ-5D affects the ICERs gen-
erated by the model. Results: The ordering of the effectiveness of treatments 
did not change with the mapping algorithm used, however there was substantial 
variation in the magnitude of the ICER. The ICER for rituximab versus DMARDs 
varied from £21,594/QALY to £32,039/QALY depending on the exact algorithm used. 
The ICER for abatacept versus rituximab varied from £124,776/QALY to £167,687/
QALY. cOnclusiOns: The cost-effectiveness results of the BRAM are heavily 
influenced by the choice of mapping algorithm. In future modelling, the choice 
of algorithm should be justified, and appropriate sensitivity analyses presented. 
Further research is needed to identify the most appropriate algorithm(s) for use 
in health technology assessment.
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Objectives: Disease-specific patient-reported outcomes (PROs) are designed to 
be highly relevant to a single disease. It is widely believed that comparisons of 
outcomes between patients with different diseases is only possible using generic 
PRO measures. The present study employs a novel method of using Rasch analy-
sis to co-calibrate scores from different disease-specific PROs allowing scores to 
be compared across diseases. MethOds: Three samples of patients completed 
the Asthma Life Impact Scale (ALIS), the Living with COPD scale (LCOPD) or the 
Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), depending on 
their illness. Each scale utilises the needs-based model of QoL and the scales 
share 8 common items. The three samples were analysed separately for fit to 
the Rasch model and then combined and re-analysed. Results: The ALIS was 
completed by 140 asthma patients (mean age= 50.6, males = 29.3%); the LCOPD 
by 162 COPD patients (mean age= 69.3, males = 43.8%) and the CAMPHOR by 91 
patients (mean age= 52.6, males = 29.7%). Each of the scales fit the Rasch model 
individually (ALIS Chi2 = 0.05; LCOPD Chi2 = 0.32; CAMPHOR Chi2 = 0.92). The com-
bined dataset also fit the Rasch model at first run (Chi2 = 0.24). One common item 
showed misfit (Chi2< 0.001) and non-uniform differential item functioning (DIF) 
by disease (Chi2< 0.001). This item was removed from the analysis and the final 
co-calibrated scale showed good fit to the Rasch model (Chi2= 0.48) with minimal 
DIF by age, gender or disease. cOnclusiOns: The results showed that it was pos-
sible to co-calibrate scores on the ALIS, LCOPD and CAMPHOR. As disease-specific 
measurement has advantages over generic assessment related to relevance and 
reproducibility, the results have the potential to enhance PRO measurement in 
respiratory research.
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Objectives: The use of pharmacoeconomic evaluations, e.g. cost-utility analysis 
(CUA), in resource allocation is gaining attention in Arabic –speaking countries. The 
Short Form-6D (SF-6D) is a generic preference-based measure of health-related 
quality of life (HRQoL) that can be used to generate health-state utilities for use in 
CUAs. The objective of this study is to translate and culturally-adapt the SF-6D for 
use in Arabic-speaking countries, with particular focus on Egypt and the United 
Arab Emirates. MethOds: The study followed the International Quality of Life 
Assessment (IQOLA) methodology. Two forward translations, one consensus and 
one backward translation were undertaken. The translators (professional linguists 
and bilingual pharmacoeconomists) reported the difficulties encountered in the 
translation process. An advisory committee of six researchers and three clini-
cians, who are native Arabic speakers and proficient in English language, assessed 
the consensus version for accuracy, cultural compatibility and cognitive burden. 
The difficulties encountered during the process were categorized as grammati-
cal, idiomatic, semantic/conceptual, and cultural. The backward translation was 
completed by a professional medical translator, reviewed and assessed by the com-
mittee. Results: Five items raised discussion during the process for grammatical 
(1 item), semantic (1 item), idiomatic (1 item) and cultural (2 items). For example, 
“emotional problems” had to be culturally adapted and “down-hearted and low” 
had to be substituted. The committee members approved the forward translation as 
linguistically and grammatically accurate. Minor changes were made to the forward 
translation to improve cultural appropriateness. The Backward translation did not 
reveal major problems and equivalence to the original was confirmed following 
committee review. cOnclusiOns: The translation and cultural adaptation of the 
SF-6D into Arabic resulted in a conceptually equivalent and culturally appropriate 
version. Psychometric validation and a valuation survey will be needed to assess 
its validity for use in the target populations.
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Objectives: Electronic formats of patient-reported outcome (PRO) measures 
are now routinely used in clinical trials. Their use promises a range of benefits 
such as improving access to patients, increasing compliance, reducing miss-
ing data and avoiding errors associated with data entry. When changing from 
paper and pen to an electronic administration it is necessary to establish their 
equivalence. This is the first study to evaluate the use of Rasch analysis for 
this purpose. MethOds: Three groups of US patients with pulmonary hyper-
tension participated. A clinical sample completed an electronic version of the 
CAMPHOR (e-sample) and two different samples completed the pen and paper 
administration (pp1 and pp2). Analyses were conducted on the CAMPHOR activity 
limitations and quality of life (QoL) scales. The three databases were analysed 
separately for fit to the Rasch model. Data were then combined, re-analysed and 
assessed for differential item functioning (DIF). Results: The three datasets 
were matched randomly for sample size (n= 147). Mean age (years) and percent-
age male respondents were as follows: e-sample (51.7, 16.0%); pp1 (50.0, 14.0%); 
pp2 (55.5, 40.4%). After minor adjustments to the three datasets, fit to the Rasch 
model was achieved (Chi2 values for activity limitations and QoL respectively 
were e-sample (0.11, 0.07); pp1 (0.18, 0.12); pp2 (0.40, 0.30)). Fit was also achieved 
for the combined sample after minor adjustments (activity limitations Chi2 = 
0.21, QoL Chi2 = 0.12). Importantly, no evidence of DIF by mode of administration 
was found. cOnclusiOns: Equivalence of the electronic and pen and paper 
administrations of the CAMPHOR was established. The results showed how the 
Rasch model can be utilized to determine the equivalence of alternative formats 
of PRO measures. This methodology has the added advantage of avoiding the 
need for complex study designs such as matching samples for disease severity 
or repeated administration of alternative formats of questionnaires.
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Objectives: Economic evaluation typically is conducted using health state 
utilities to estimate treatment benefits. However, such outcomes are often miss-
ing from studies of clinical effectiveness. This study aims to bridge that gap by 
providing appropriate methods to link values from the Western Ontario and 
McMaster Universities Osteoarthritis Index (WOMAC) to the EQ-5D utility instru-
ment. MethOds: Patients from a large registry of Spanish patients (n= 7072 obser-
vations) with knee or hip osteoarthritis who completed both WOMAC and EQ-5D 
was used. A mixture model approach was used based on distributions bespoke to 
the EQ-5D UK value set to estimate EQ-5D as a function of WOMAC pain, stiffness 
and function subscores. Results: A five class mixture model provides very close 
fit to the observed data at all levels of disease severity. The overall mean (0.542 vs 
0.542), median (0.620 vs 0.636) and the percentage of observations at full health 
(15 vs 14.8) were very similar between the observed data and the estimated model 
respectively. Stiffness has limited relationship to EQ-5D, whereas functional disabil-
ity and pain are strong predictors. cOnclusiOns: EQ-5D can be reliably estimated 
from WOMAC subscale scores without any systematic bias using the results based 
on a bespoke mixture model method.
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ateness of the resulting test questionnaire. After revision, the pilot questionnaire 
was created. Results: Concepts elicited during group discussions revolved around 
pleasure and health. The test questionnaire consisted of 199 items divided into six 
modules: “grocery shopping”, “cooking”, “places where meals are eaten”, “convivial-
ity”, “eating and drinking”, and “eating habits and health”. Items within the first 
five modules assess subject behaviour and benefits (pleasure, psychology, digestion, 
physical condition); the module “eating habits and health” assesses beliefs. Cognitive 
interviews led to minor rewordings, removal and addition of items. The resulting pilot 
questionnaire consisted of 174 items distributed across the 6 aforementioned mod-
ules. cOnclusiOns: We developed a unique tool that comprehensively assesses the 
full picture of well-being related to food and eating habits in the general population. A 
validation study is underway to establish the scoring and ascertain the psychometrics 
of the instrument before it can be used in clinical studies.
PRM174
MeThoDology anD DeveloPMenT of ‘PolIsh DIcTIonaRy of QualITy of 
lIfe TeRMs’
Golicki D.1, Farkowski M.M.2, Grabowska-Krawiec P.3, Szkultecka-Debek M.4, Zawodnik S.5, 
Baran J.6, Borowiec L.7, Czech M.5
1Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, 
Poland, 2Institute of Cardiology, Warsaw, Poland, 3Department of Immunology and Clinical 
Allergology, Military Institute of Medicine, Warsaw, Poland, 4Department of Dermatology, Military 
Institute of Medicine, Warsaw, Poland, 5Department of Pharmacoeconomics, Medical University of 
Warsaw, Warsaw, Poland, 6Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland, 
7Servier Polska Sp. z o.o., Warsaw, Poland
Lack of an established Polish terminology is a serious limitation of the development 
of health-related quality of life (HRQoL) studies in Poland. Objectives: To develop 
Polish dictionary of terms used in the studies of HRQoL. MethOds: In February 2012, 
HRQoL Special Interest Group of ISPOR Poland Chapter took on the task of preparing 
Polish dictionary of HRQoL terms. Following steps were planned: (1) preparation of 
a list of target English-language terms, (2) preparation of a reference list of transla-
tions typically used in Polish literature, (3) step-by-step translation of English terms 
by individual experts (4) analysis and approval of proposed translations by Expert 
Committee, (5) re-analysis of key terms, (6) preparation of pre-final vocabulary, (7) 
reviews by Review Committee, (8) preparation and publication of the final version. 
The list of English terms was based on following sources: popular English-language 
HRQoL textbooks, key words from papers published in leading peer-reviewed jour-
nals in the field, ISPOR guidelines concerning patient-reported outcomes, websites of 
generic HRQoL instruments. The reference lists of translations used in Polish literature 
was based on pharmacoeconomics and psychology textbooks, EBM dictionaries and 
HRQoL papers published in Polish peer-reviewed journals. Expert Committee was 
comprised of seven Polish investigators with vast experience in the field of HRQoL 
studies. Review Committee was formed by three authorities in the field of psycho-
metrics, statistics and epidemiology. Results: Till June 2013, there were 13 meetings 
of Expert Committee: three focused on the development of methodology and ten - on 
analysis and approval of proposed translations. Initially, we identified 1640 English 
terms from different sources. After removal of duplicates, final English list comprised 
of 1314 terms. Pre-final version of vocabulary, ready for peer-review, consists of 1051 
proposed Polish translations. cOnclusiOns: We anticipate, that dictionary prepared 
by the ISPOR Poland Chapter will support practical usage of PRO in Poland.
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Objectives: The lack of preference-based utility data places great importance 
on the accuracy of mapping functions. The objective of this study is to assess the 
predictive accuracy of statistical models which address the unique properties of 
EQ-5D. MethOds: A large dataset from the Patient Reported Outcome Measures 
(PROMs) programme reporting EQ-5D and OHS values for patients who have under-
gone total hip replacement, during April 2010 and March 2011, was used to develop 
6 mapping functions using different statistical methods: Ordinary Least Squares 
(OLS), standard Tobit, adjusted Tobit, two-part logit (TPL), response-mapping and 
censored least absolute deviation (CLAD). Three different model specifications 
were investigated, including the total OHS, individual item score and individual 
item responses. Each model specification was examined using goodness-of fit 
measures. The predictive accuracy of each model was analysed using the mean 
absolute error (MAE) and mean squared error (MSE). Model performance was com-
pared in an internal and external validation. Results: The OHS individual item 
response variables proved to give the best model fit and were therefore used 
across all models. The OLS and TPL models consistently demonstrated the highest 
predictive accuracy, providing the lowest MSE and the closest estimation of the 
mean EQ-5D. The response-mapping approach was the poorest predictor in esti-
mating individual values; however it was able to predict the median with perfect 
precision. Models using Tobit and CLAD frameworks provided the poorest predic-
tions. cOnclusiOns: The OLS and TPL models proved to be the most accurate 
in predicting EQ-5D on an individual level, whilst the response-mapping model 
is recommended for predicting the median. Using inaccurate mapping functions 
such as the Tobit models developed in this study can have a substantial impact 
on CEA results and reimbursement decisions.
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